These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32208559)

  • 1. Eli Lilly and Company Insulins - A Century of Innovation.
    Malone JK; Anderson JHJ; Wolpert HA; Ilag LL; Frank BH; De Felippis MR; Paavola CD; Orr AL; Beals JM
    Pediatr Endocrinol Rev; 2020 Mar; 17(Suppl 1):138-160. PubMed ID: 32208559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the role of concentrated insulin in diabetes management?
    Mospan CM
    JAAPA; 2016 Jun; 29(6):16-8. PubMed ID: 27228041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding concentrated insulins: a systematic review of randomized controlled trials.
    Ovalle F; Segal AR; Anderson JE; Cohen MR; Morwick TM; Jackson JA
    Curr Med Res Opin; 2018 Jun; 34(6):1029-1043. PubMed ID: 29166786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A UK analysis of the cost-effectiveness of Humalog Mix75/25 and Mix50/50 versus long-acting basal insulin.
    Pollock RF; Curtis BH; Smith-Palmer J; Valentine WJ
    Adv Ther; 2012 Dec; 29(12):1051-66. PubMed ID: 23179373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of insulin development: focus on key parameters.
    Tibaldi JM
    Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The short-acting insulin analog Lispro (Humalog) in the treatment of diabetes--comparison of preprandial and postprandial administration and comparison with treatment using Humulin R].
    Perusicová J; Svehelka JM
    Vnitr Lek; 1998 Jul; 44(7):409-14. PubMed ID: 9748877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide: AC 2993, AC002993, AC2993A, exendin 4, LY2148568.
    Drugs R D; 2004; 5(1):35-40. PubMed ID: 14725490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.
    Vaughn DE; Yocum RC; Muchmore DB; Sugarman BJ; Vick AM; Bilinsky IP; Frost GI
    Diabetes Technol Ther; 2009 Jun; 11(6):345-52. PubMed ID: 19459762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins.
    Nolte MS; Poon V; Grodsky GM; Forsham PH; Karam JH
    Diabetes; 1983 Dec; 32(12):1177-81. PubMed ID: 6360762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrated insulins in current clinical practice.
    Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
    Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolution of Insulin and How it Informs Therapy and Treatment Choices.
    Hirsch IB; Juneja R; Beals JM; Antalis CJ; Wright EE
    Endocr Rev; 2020 Oct; 41(5):733-55. PubMed ID: 32396624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulins for type 2 diabetes.
    Med Lett Drugs Ther; 2019 May; 61(1571):65-68. PubMed ID: 31169803
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.
    Tieu C; Lucas EJ; DePaola M; Rosman L; Alexander GC
    PLoS One; 2018; 13(4):e0195012. PubMed ID: 29668697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative insulins--where do analogues fit?
    Phillips LK; Phillips PJ
    Aust Fam Physician; 2006 Dec; 35(12):969-73. PubMed ID: 17149471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulary Considerations for Insulins Approved Through the 505(b)(2) "Follow-on" Pathway.
    Rasmussen JT; Ipema HJ
    Ann Pharmacother; 2019 Feb; 53(2):204-210. PubMed ID: 30122087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of insulin therapy in diabetes mellitus.
    Heile M; Schneider D
    J Fam Pract; 2012 May; 61(5 Suppl):S6-12. PubMed ID: 22577636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.